3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Endocrine
2
Conditions
Breast Neoplasms
2234
Neoplasms
2039
Lung Neoplasms
1097
Colorectal Neoplasms
1036
Prostatic Neoplasms
894
Carcinoma, Non-Small-Cell Lung
752
Carcinoma, Hepatocellular
674
Stomach Neoplasms
607
Pancreatic Neoplasms
602
Head and Neck Neoplasms
434
Ovarian Neoplasms
430
Colonic Neoplasms
423
Rectal Neoplasms
406
Uterine Cervical Neoplasms
403
Esophageal Neoplasms
347
Brain Neoplasms
329
Neoplasm Metastasis
324
Melanoma
306
Multiple Myeloma
304
Precursor Cell Lymphoblastic Leukemia-Lymphoma
293
Urinary Bladder Neoplasms
290
Leukemia, Myeloid, Acute
278
Lymphoma
268
Liver Neoplasms
253
Endometrial Neoplasms
253
Hematologic Neoplasms
252
Disease
244
Recurrence
225
Glioma
218
Carcinoma, Renal Cell
207
Interventions
Biomarkers
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Observational
×
ACTH-Secreting Pituitary Adenoma
×
Clear all
NCT07463625
2026-03-11
PiTFET
Hospices Civils de Lyon
Recruiting
20 enrolled
NCT06701838
2024-12-03
OPTIMAL
Imperial College London
Not yet recruiting
15 enrolled